These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34190390)

  • 1. Feasibility of oral tranexamic acid for vitiligo patients with melasma.
    Chiang PH; Lin YJ; Chiu YC; Chung WH; Ku CL; Ng CY
    Dermatol Ther; 2021 Sep; 34(5):e15047. PubMed ID: 34190390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis.
    Lee HC; Thng TG; Goh CL
    J Am Acad Dermatol; 2016 Aug; 75(2):385-92. PubMed ID: 27206758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of the combination of tranexamic acid injection and electro-optical synergy (ELOS) versus tranexamic acid injection alone in the treatment of melasma.
    Wang Y; Tang L; Duan J; Wang L; Ye F
    Lasers Med Sci; 2023 Aug; 38(1):179. PubMed ID: 37552377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
    Badran AY; Ali AU; Gomaa AS
    Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tranexamic acid 5% cream vs hydroquinone 4% cream in treating melasma: A split-face comparative clinical, histopathological, and antera 3D camera study.
    El-Husseiny R; Rakha N; Sallam M
    Dermatol Ther; 2020 Nov; 33(6):e14240. PubMed ID: 32856757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment.
    Polat Y; Saraç G
    Dermatol Ther; 2022 Jul; 35(7):e15499. PubMed ID: 35395121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral tranexamic acid with a triple combination cream versus oral tranexamic acid monotherapy in the treatment of severe melasma.
    Martinez-Rico JC; Chavez-Alvarez S; Herz-Ruelas ME; Sosa-Colunga SA; Ocampo-Candiani J; Suro-Santos Y; Vazquez Martinez O
    J Cosmet Dermatol; 2022 Aug; 21(8):3451-3457. PubMed ID: 35340120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the efficacy of Myjet-assisted tranexamic acid and vitamin C in treating melasma: A split-face controlled trial.
    Zhao H; Li M; Zhang X; Li L; Yan Y; Wang B
    J Cosmet Dermatol; 2020 Jan; 19(1):47-54. PubMed ID: 31479196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study.
    Karrabi M; Mansournia MA; Sharestanaki E; Abdollahnejad Y; Sahebkar M
    Arch Dermatol Res; 2021 Sep; 313(7):539-547. PubMed ID: 32879998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma.
    Botsali A; Esme P; Erbil H; Caliskan E
    Lasers Med Sci; 2022 Sep; 37(7):2823-2830. PubMed ID: 35347552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
    Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
    Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of melasma with oral administration of tranexamic acid.
    Wu S; Shi H; Wu H; Yan S; Guo J; Sun Y; Pan L
    Aesthetic Plast Surg; 2012 Aug; 36(4):964-70. PubMed ID: 22552446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study.
    Zhu CY; Li Y; Sun QN; Takada A; Kawada A
    Eur J Dermatol; 2019 Feb; 29(1):55-58. PubMed ID: 30734717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of topical tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasma.
    Xing X; Chen L; Xu Z; Jin S; Zhang C; Xiang L
    J Cosmet Dermatol; 2020 Dec; 19(12):3238-3244. PubMed ID: 33091202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
    Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
    J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.